ZA868740B - Phenoxyalkylcarboxylic acids and esters and their preparation and pharmaceutical formulation - Google Patents

Phenoxyalkylcarboxylic acids and esters and their preparation and pharmaceutical formulation

Info

Publication number
ZA868740B
ZA868740B ZA868740A ZA868740A ZA868740B ZA 868740 B ZA868740 B ZA 868740B ZA 868740 A ZA868740 A ZA 868740A ZA 868740 A ZA868740 A ZA 868740A ZA 868740 B ZA868740 B ZA 868740B
Authority
ZA
South Africa
Prior art keywords
integer
esters
preparation
pharmaceutical formulation
group
Prior art date
Application number
ZA868740A
Other languages
English (en)
Inventor
Peter Hallett
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA868740B publication Critical patent/ZA868740B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/34—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
ZA868740A 1985-11-19 1986-11-18 Phenoxyalkylcarboxylic acids and esters and their preparation and pharmaceutical formulation ZA868740B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858528398A GB8528398D0 (en) 1985-11-19 1985-11-19 Chemical compounds

Publications (1)

Publication Number Publication Date
ZA868740B true ZA868740B (en) 1987-07-29

Family

ID=10588403

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA868740A ZA868740B (en) 1985-11-19 1986-11-18 Phenoxyalkylcarboxylic acids and esters and their preparation and pharmaceutical formulation

Country Status (14)

Country Link
EP (1) EP0223593B1 (pt)
JP (1) JPS62155250A (pt)
KR (1) KR870004950A (pt)
AT (1) ATE65992T1 (pt)
AU (1) AU593039B2 (pt)
DE (1) DE3680753D1 (pt)
DK (1) DK550186A (pt)
FI (1) FI864692A (pt)
GB (2) GB8528398D0 (pt)
IL (1) IL80701A0 (pt)
NO (1) NO864599L (pt)
PH (1) PH23837A (pt)
PT (1) PT83762B (pt)
ZA (1) ZA868740B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3610643A1 (de) * 1986-03-29 1987-10-01 Boehringer Mannheim Gmbh Neue phenoxyalkylcarbonsaeure-derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
DE3642105A1 (de) * 1986-12-10 1988-06-16 Bayer Ag Substituierte aminomethyl-5,6,7,8-tetrahydronaphtyl-oxyessigsaeuren, neue zwischenprodukte, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
AT396235B (de) * 1987-02-06 1993-07-26 Tanabe Seiyaku Co Phenoxyessigsaeurederivate und ihre herstellung
GB8708233D0 (en) * 1987-04-07 1987-05-13 Smith Kline French Lab Pharmaceutically active compounds
JPH068275B2 (ja) * 1988-02-04 1994-02-02 田辺製薬株式会社 フェノキシ酢酸誘導体
EP0325245B1 (en) * 1988-01-19 1993-10-20 Tanabe Seiyaku Co., Ltd. Phenoxyacetic acid derivatives, preparation thereof, pharmaceutical compositions comprising them and use
JPH068274B2 (ja) * 1988-01-19 1994-02-02 田辺製薬株式会社 フェノキシ酢酸誘導体
DE3821540A1 (de) * 1988-06-25 1989-12-28 Boehringer Mannheim Gmbh Neue sulfonamide, verfahren zu ihrer herstellung sowie solche sulfonamide enthaltende arzneimittel
DE3829431A1 (de) * 1988-08-31 1990-03-01 Boehringer Mannheim Gmbh Sulfonamide mit tetrazolylrest, verfahren zur ihrer herstellung sowie arzneimittel
US5280043A (en) * 1988-10-10 1994-01-18 Smith Kline & French Laboratories Ltd. Sulphonamido containing phenylalkanoic acids as thromboxane A2 antagonists
US5070099A (en) * 1988-10-31 1991-12-03 E. R. Squibb & Sons, Inc. Arylthioalkylphenyl carboxylic acids, derivatives thereof, compositions containing same method of use
US4959383A (en) * 1988-10-31 1990-09-25 E. R. Squibb & Sons, Inc. Phenylsulfone alkenoic acids, derivatives thereof, compositions containing same and method of use
US5006542A (en) * 1988-10-31 1991-04-09 E. R. Squibb & Sons, Inc. Arylthioalkylphenyl carboxylic acids, derivatives thereof, compositions containing same and method of use
DE3942923A1 (de) * 1989-12-23 1991-06-27 Boehringer Mannheim Gmbh Neue phenoxyalkylcarbonsaeure-amide, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
DE4031821A1 (de) * 1990-10-08 1992-04-09 Boehringer Mannheim Gmbh Verwendung von thromboxan-a2-rezeptoren-antagonisten gegen proliferative veraenderungen in der gefaesswand
ES2117264T3 (es) * 1993-03-17 1998-08-01 Meiji Seika Co Nuevo compuesto con actividad inhibitoria de la agregacion plaquetaria.
US6242493B1 (en) 1998-03-13 2001-06-05 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
WO1999047497A2 (en) * 1998-03-13 1999-09-23 Merck Frosst Canada & Co. Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
WO2001051454A1 (en) * 2000-01-13 2001-07-19 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
WO2007008541A2 (en) * 2005-07-08 2007-01-18 Kalypsys, Inc. Cellular cholesterol absorption modifiers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809377A1 (de) * 1978-03-04 1979-09-13 Boehringer Mannheim Gmbh Phenoxyalkylcarbonsaeure-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3535167A1 (de) * 1985-10-02 1987-04-09 Boehringer Mannheim Gmbh Neue sulfonyl-phenyl(alkyl)amine, verfahren zu ihrer herstellung sowie arzneimittel
DE3610643A1 (de) * 1986-03-29 1987-10-01 Boehringer Mannheim Gmbh Neue phenoxyalkylcarbonsaeure-derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
DE3680753D1 (de) 1991-09-12
NO864599L (no) 1987-05-20
FI864692A (fi) 1987-05-20
GB8528398D0 (en) 1985-12-24
GB8627512D0 (en) 1986-12-17
AU6550586A (en) 1987-05-21
KR870004950A (ko) 1987-06-02
JPS62155250A (ja) 1987-07-10
ATE65992T1 (de) 1991-08-15
AU593039B2 (en) 1990-02-01
EP0223593A3 (en) 1989-01-18
DK550186D0 (da) 1986-11-18
PT83762B (en) 1988-12-07
GB2183234A (en) 1987-06-03
PH23837A (en) 1989-11-23
FI864692A0 (fi) 1986-11-18
PT83762A (en) 1986-12-01
GB2183234B (en) 1989-10-04
EP0223593B1 (en) 1991-08-07
DK550186A (da) 1987-05-20
IL80701A0 (en) 1987-02-27
NO864599D0 (no) 1986-11-18
EP0223593A2 (en) 1987-05-27

Similar Documents

Publication Publication Date Title
IL80701A0 (en) Phenoxyalkylcarboxylic acids and esters and their preparation and pharmaceutical formulation
AU4257889A (en) Sulphonamido-phenylalkanoic acid derivatives having thromboxane A2 antagonist activity
PT87987A (pt) Processo para a preparacao de derivados de arilo do acido hidroxamico ou efeito anti-inflamatorio e de composicoes farmaceuticas que os contem
HUT45230A (en) Process for producing new phenoxy-acetic acid derivatives and pharmaceuticals comprising such compounds
NO171906C (no) Analogifremgangsmaate for fremstilling av anti-inflammatorisk aktive arylforbindelser
ATE110568T1 (de) Pharmazeutisches präparat zur behandlung des katarakts.
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
FI104169B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1H-substituoitujen aryylipyratsolijohdannaisten valmistamiseksi
FR2580648B1 (fr) Nouveaux derives du triazole, leur procede de preparation et les compositions pharmaceutiques les renfermant
IE782005L (en) Pharmaceutical compositions
JPS5651452A (en) Derivative of acylated indole, its preparation and blood platelet coagulation suppressing agent containing said compound as effective component